Essex Woodlands Management, Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Essex Woodlands Management, Inc.
- $279 Million
- Q2 2025
A detailed history of Essex Woodlands Management, Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Essex Woodlands Management, Inc. holds 1,169,857 shares of EYPT stock, worth $12.6 Million. This represents 3.95% of its overall portfolio holdings.
Number of Shares
1,169,857
Previous 1,169,857
-0.0%
Holding current value
$12.6 Million
Previous $6.34 Million
73.63%
% of portfolio
3.95%
Previous 1.83%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
160Shares Held
67.1MCall Options Held
209KPut Options Held
988K-
Cormorant Asset Management, LP Boston, MA8.33MShares$89.5 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$73.1 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$73.1 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$49.4 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$46.2 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $366M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...